Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline and Metformin versus Placebo for the Treatment of Patients with Nonalcoholic Steatohepatitis
TCTR20130528001Phase 2Recruiting
- Sponsor
- Gastroenterological Association of Thailand
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pentoxifylline, metformin in metabolic dysfunction-associated steatohepatitis (MASH), sponsored by Gastroenterological Association of Thailand. Started Dec 2012; status: recruiting.
02
Drugs
pentoxifyllinemetformin
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on TCTR20130528001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20130528001.